Nifedipine, a new antihypertensive with rapid action

Area of Science:

• Cardiology
• Pharmacology

Background:

• Severe primary hypertension poses significant cardiovascular risks.
• Effective and rapid-acting antihypertensive agents are crucial for managing hypertensive emergencies.

Purpose of the Study:

• To evaluate the efficacy of nifedipine in reducing blood pressure in patients with severe primary hypertension.
• To assess the onset and magnitude of blood pressure reduction following oral and sublingual nifedipine administration.

Main Methods:

• Oral or sublingual administration of 10 mg nifedipine to patients with severe primary hypertension.
• Monitoring of blood pressure, mean arterial pressure, peripheral resistance, cardiac output, and pulse rate.
• Case study of nifedipine administration in patients with hypertensive encephalopathy and acute left ventricular failure.

Main Results:

• Prompt blood pressure reduction observed within 5-20 minutes after administration.
• Maximal mean arterial pressure reduction averaged 36 mm Hg, with a 19.5% decrease from control at 120 minutes.
• Hypotension was mediated by decreased peripheral resistance, increased cardiac output, and pulse rate.
• Significant blood pressure reduction in patients with hypertensive encephalopathy and acute left ventricular failure.

Conclusions:

• Nifedipine is an effective agent for rapid blood pressure reduction in severe primary hypertension.
• Sublingual administration offers a faster onset of action compared to oral administration.
• Nifedipine demonstrates utility in managing hypertensive emergencies, including hypertensive encephalopathy and acute left ventricular failure.